The serotonin 5-HT4 receptor and the amyloid precursor protein processing

被引:51
|
作者
Lezoualc'h, F [1 ]
Robert, SJ
机构
[1] Univ Paris Sud, Inst Signalisat & Innovat Therapeut IFR 75, Fac Pharm, INSERM,U Cardiol Cellulaire & Mol 446, F-92296 Chatenay Malabry, France
[2] Univ Paris Sud, Inst Signalisat & Innovat Therapeut IFR 75, Fac Pharm, UPRES,EAD2707, F-92296 Chatenay Malabry, France
关键词
acetylcholine; Alzheimer's disease; G protein coupled-receptor; serotonin; 5-HT4; receptor; amyloid precursor protein;
D O I
10.1016/S0531-5565(02)00157-2
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
A large body of evidence supports a major role for the serotonin 5-HT4 receptor in learning and memory and it is suggested that 5-HT4 agonists may be beneficial for memory disorders such as Alzheimer's disease (AD). The 5-HT4 receptors are members of the G protein-coupled receptor superfamily and are positively coupled to adenylyl cyclase. In this communication we show that a neuronal isoform of the human 5-HT4 receptor, h5-HT4(g) regulates the metabolism of the amyloid precursor protein (APP695). This process is observed in Chinese hamster ovary (CHO) cells stably coexpressing the neuronal h5-HT4(g) receptor isoform as well as the human APP695. The 5-HT4 agonists strongly stimulate the release of the non-amyloidogenic soluble amyloid precursor protein sAPPalpha as detected by immunoblot. Prucalopride was more potent than serotonin (5-HT) with regard to enhanced of sAPPalpha secretion. This process was blocked by a selective 5-HT4 antagonist, GR113808. Furthermore, 5-HT4 ligands enhance sAPPalpha secretion via cAMP-dependent and PKA-independent signalling pathways indicating there are alternative pathways by which the h5-HT4 receptor via cAMP regulates APP metabolism. Because the alpha-cleavage event may preclude the formation of amyloidogenic peptides, and secreted sAPPalpha has putative neuroprotective and enhancing-memory properties, our present data suggest the 5-HT4 receptor as a novel target for the treatment of AD. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:159 / 166
页数:8
相关论文
共 50 条
  • [31] A Hybrid Structural Approach to Analyze Ligand Binding by the Serotonin Type 4 Receptor (5-HT4)
    Padayatti, Pius S.
    Wang, Liwen
    Gupta, Sayan
    Orban, Tivadar
    Sun, Wenyu
    Salom, David
    Jordan, Steven R.
    Palczewski, Krzysztof
    Chance, Mark R.
    MOLECULAR & CELLULAR PROTEOMICS, 2013, 12 (05) : 1259 - 1271
  • [32] NEW AZA(NOR)ADAMANTANES ARE AGONISTS AT THE NEWLY IDENTIFIED SEROTONIN 5-HT4 RECEPTOR AND ANTAGONISTS AT THE 5-HT3 RECEPTOR
    FLYNN, DL
    BECKER, DP
    SPANGLER, DP
    NOSAL, R
    GULLIKSON, GW
    MOUMMI, C
    YANG, DC
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1992, 2 (12) : 1613 - 1618
  • [33] Clinical Pharmacokinetics of Tegaserod, a Serotonin 5-HT4 Receptor Partial Agonist with Promotile Activity
    Silke Appel-Dingemanse
    Clinical Pharmacokinetics, 2002, 41 : 1021 - 1042
  • [34] Clinical pharmacokinetics of tegaserod, a serotonin 5-HT4 receptor partial agonist with promotile activity
    Appel-Dingemanse, S
    CLINICAL PHARMACOKINETICS, 2002, 41 (13) : 1021 - 1042
  • [35] Discovery of a potentand selective serotonin 5-HT4 receptor agonist BS-0160.
    Yamazaki, H
    Harada, H
    Hirokawa, Y
    Kan, Y
    Mine, Y
    Yoshida, N
    Kato, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U211 - U212
  • [36] Multivalent-Based Drug Design Applied to Serotonin 5-HT4 Receptor Oligomers
    Lezoualc'h, Frank
    Jockers, Ralf
    Berque-Bestel, Isabelle
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (06) : 719 - 729
  • [37] Roles of the serotonin 5-HT4 receptor in dendrite formation of the rat hippocampal neurons in vitro
    Kozono, Naoki
    Ohtani, Akiko
    Shiga, Takashi
    BRAIN RESEARCH, 2017, 1655 : 114 - 121
  • [38] The 5-HT4 receptor antagonist ML10375 inhibits the constitutive activity of human 5-HT4(c) receptor
    Blondel, O
    Gastineau, M
    Langlois, M
    Fischmeister, R
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (04) : 595 - 597
  • [39] Pharmacological profile of engineered 5-HT4 receptors and identification of 5-HT4 receptor-biased ligands
    Gaven, Florence
    Pellissier, Lucie P.
    Queffeulou, Emilie
    Cochet, Maud
    Bockaert, Joel
    Dumuis, Aline
    Claeysen, Sylvie
    BRAIN RESEARCH, 2013, 1511 : 65 - 72
  • [40] A pharmacodynamic model of 5-HT4 receptor activation in man: Antagonism by the 5-HT4 receptor antagonist SB-207266
    Cooper, SM
    Haydock, SF
    Tompson, DJ
    Higgins, RG
    Fitzpatrick, KL
    GASTROENTEROLOGY, 1999, 116 (04) : A598 - A598